BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 12076251)

  • 1. The cyclo-oxygenase-2 inhibitor celecoxib perturbs intracellular calcium by inhibiting endoplasmic reticulum Ca2+-ATPases: a plausible link with its anti-tumour effect and cardiovascular risks.
    Johnson AJ; Hsu AL; Lin HP; Song X; Chen CS
    Biochem J; 2002 Sep; 366(Pt 3):831-7. PubMed ID: 12076251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Celecoxib-induced increase in cytosolic Ca(2+) levels and apoptosis in HA59T human hepatoma cells.
    Cheng HH; Chou CT; Lu YC; Lu T; Chi CC; Tseng LL; Liu SI; Cheng JS; Kuo CC; Liang WZ; Jan CR
    Hum Exp Toxicol; 2014 Nov; 33(11):1089-98. PubMed ID: 24972620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of celecoxib on Ca2+ movement and cell proliferation in human osteoblasts.
    Wang JL; Lin KL; Chen JS; Lu YC; Jiann BP; Chang HT; Hsu SS; Chen WC; Huang JK; Ho CM; Jan CR
    Biochem Pharmacol; 2004 Mar; 67(6):1123-30. PubMed ID: 15006548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Celecoxib activates a novel mitochondrial apoptosis signaling pathway.
    Jendrossek V; Handrick R; Belka C
    FASEB J; 2003 Aug; 17(11):1547-9. PubMed ID: 12824303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of celecoxib on Ca(2+) handling and viability in human prostate cancer cells (PC3).
    Wang JL; Lin KL; Chou CT; Kuo CC; Cheng JS; Hsu SS; Chang HT; Tsai JY; Liao WC; Lu YC; Chen IS; Liu SI; Jan CR
    Drug Chem Toxicol; 2012 Oct; 35(4):456-62. PubMed ID: 22168270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-proliferative and apoptotic effects of celecoxib on human chronic myeloid leukemia in vitro.
    Subhashini J; Mahipal SV; Reddanna P
    Cancer Lett; 2005 Jun; 224(1):31-43. PubMed ID: 15911099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells.
    Lev-Ari S; Strier L; Kazanov D; Madar-Shapiro L; Dvory-Sobol H; Pinchuk I; Marian B; Lichtenberg D; Arber N
    Clin Cancer Res; 2005 Sep; 11(18):6738-44. PubMed ID: 16166455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apoptosis induction and enhancement of cytotoxicity of anticancer drugs by celecoxib, a selective cyclooxygenase-2 inhibitor, in human head and neck carcinoma cell lines.
    Hashitani S; Urade M; Nishimura N; Maeda T; Takaoka K; Noguchi K; Sakurai K
    Int J Oncol; 2003 Sep; 23(3):665-72. PubMed ID: 12888902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of calcium, pH, and cell proliferation in the programmed (apoptotic) death of androgen-independent prostatic cancer cells induced by thapsigargin.
    Furuya Y; Lundmo P; Short AD; Gill DL; Isaacs JT
    Cancer Res; 1994 Dec; 54(23):6167-75. PubMed ID: 7954463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2,5-Dimethyl-celecoxib inhibits cell cycle progression and induces apoptosis in human leukemia cells.
    Sobolewski C; Rhim J; Legrand N; Muller F; Cerella C; Mack F; Chateauvieux S; Kim JG; Yoon AY; Kim KW; Dicato M; Diederich M
    J Pharmacol Exp Ther; 2015 Nov; 355(2):308-28. PubMed ID: 26330537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclooxygenase-2 inhibitor celecoxib augments chemotherapeutic drug-induced apoptosis by enhancing activation of caspase-3 and -9 in prostate cancer cells.
    Dandekar DS; Lopez M; Carey RI; Lokeshwar BL
    Int J Cancer; 2005 Jun; 115(3):484-92. PubMed ID: 15688368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Celecoxib exhibits the greatest potency amongst cyclooxygenase (COX) inhibitors for growth inhibition of COX-2-negative hematopoietic and epithelial cell lines.
    Waskewich C; Blumenthal RD; Li H; Stein R; Goldenberg DM; Burton J
    Cancer Res; 2002 Apr; 62(7):2029-33. PubMed ID: 11929821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium-activated endoplasmic reticulum stress as a major component of tumor cell death induced by 2,5-dimethyl-celecoxib, a non-coxib analogue of celecoxib.
    Pyrko P; Kardosh A; Liu YT; Soriano N; Xiong W; Chow RH; Uddin J; Petasis NA; Mircheff AK; Farley RA; Louie SG; Chen TC; Schönthal AH
    Mol Cancer Ther; 2007 Apr; 6(4):1262-75. PubMed ID: 17431104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest, caspase-3 activation, and downregulation of Cox-2 expression and are synergistic with hydroxyurea or imatinib.
    Zhang GS; Liu DS; Dai CW; Li RJ
    Am J Hematol; 2006 Apr; 81(4):242-55. PubMed ID: 16550520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Celecoxib inhibits interleukin-12 alphabeta and beta2 folding and secretion by a novel COX2-independent mechanism involving chaperones of the endoplasmic reticulum.
    Alloza I; Baxter A; Chen Q; Matthiesen R; Vandenbroeck K
    Mol Pharmacol; 2006 May; 69(5):1579-87. PubMed ID: 16467190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of endoplasmic reticulum calcium content in prostate cancer cell growth regulation by IGF and TNFalpha.
    Humez S; Legrand G; Vanden-Abeele F; Monet M; Marchetti P; Lepage G; Crepin A; Dewailly E; Wuytack F; Prevarskaya N
    J Cell Physiol; 2004 Nov; 201(2):201-13. PubMed ID: 15334655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms underlying the growth inhibitory effects of the cyclo-oxygenase-2 inhibitor celecoxib in human breast cancer cells.
    Basu GD; Pathangey LB; Tinder TL; Gendler SJ; Mukherjee P
    Breast Cancer Res; 2005; 7(4):R422-35. PubMed ID: 15987447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition mechanism of the intracellular transporter Ca2+-pump from sarco-endoplasmic reticulum by the antitumor agent dimethyl-celecoxib.
    Coca R; Soler F; Cortés-Castell E; Gil-Guillén V; Fernández-Belda F
    PLoS One; 2014; 9(7):e102083. PubMed ID: 25003576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ribosome-translocon complex mediates calcium leakage from endoplasmic reticulum stores.
    Van Coppenolle F; Vanden Abeele F; Slomianny C; Flourakis M; Hesketh J; Dewailly E; Prevarskaya N
    J Cell Sci; 2004 Aug; 117(Pt 18):4135-42. PubMed ID: 15280427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the selective COX-2 inhibitors celecoxib and rofecoxib on human vascular cells.
    Niederberger E; Manderscheid C; Grösch S; Schmidt H; Ehnert C; Geisslinger G
    Biochem Pharmacol; 2004 Jul; 68(2):341-50. PubMed ID: 15194006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.